healthcare.digital September 12, 2023
Exec Summary:
The non-invasive continuous blood glucose monitoring (NGBGM) market is expected to grow significantly in the coming years. This growth is being driven by a number of factors, including the increasing prevalence of diabetes, the rising demand for wearable devices, and the development of new NGBGM technologies that make blood glucose monitoring more convenient and affordable.
The growth of the NGBGM market is expected to drive M&A activity in the healthtech sub sector in 2024. Companies that are developing new NGBGM technologies or that are looking to expand their reach in the market are expected to be active in M&A deals.
Here are some of the key M&A trends predicted in...
Today's Sponsors
Today's Sponsor